Scholarly Index
W. Kimryn Rathmell
Vanderbilt University Medical Center; 106,741 total citations; 422 total publications; best world rank #28
Vanderbilt University Medical Center
106,741Total citations
422Total publications
109H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal cell carcinoma treatment | Lifetime | 28 | US 21 | 99.77 |
| Cancer Genomics and Diagnostics | Lifetime | 102 | US 68 | 99.74 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 95 | US 46 | 99.63 |
| Renal and related cancers | Lifetime | 40 | US 29 | 99.65 |
| Ferroptosis and cancer prognosis | Lifetime | 72 | US 31 | 98.69 |
| Epigenetics and DNA Methylation | Lifetime | 602 | US 318 | 98.57 |
| Health and Medical Research Impacts | Lifetime | 493 | US 285 | 91.57 |
| Advances in Oncology and Radiotherapy | Lifetime | 583 | US 280 | 91.02 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 155 | US 43 | 95.62 |
| Health and Medical Research Impacts | 2021-2025 | 30 | US 15 | 94.43 |
| Renal cell carcinoma treatment | 2021-2025 | 277 | US 104 | 95.53 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 102 | US 43 | 92.26 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 256 | US 166 | 92.81 |
| Immune cells in cancer | 2021-2025 | 756 | US 160 | 89.52 |
| Renal and related cancers | 2021-2025 | 449 | US 179 | 88.44 |
| Cancer Research and Treatments | 2021-2025 | 869 | US 229 | 79.46 |